Patent Assignment
Reel/Frame 044588/0716
Assignment of Assignor's Interest
Recorded: 2018-01-10
Pages: 6
Assignor
STEVENS, RAYMOND E.
Executed: 2017-12-06
Assignee
VELICEPT THERAPEUTICS, INC.
101 LINDEENWOOD DRIVE, SUITE 400, MALVERN, PENNSYLVANIA, 19355
Covered Properties
(3)
Dosing Regimens for Beta-3 Adrenoceptor Agonists and Anti-Muscarinic Agents for the Treatment and Prevention of Lower Urinary Tract Symptoms and Overactive Bladder
Compositions and Methods of Using Modified Release Beta-3 Adrenoceptor Agonists for Lower Urinary Tract Symptoms
Application:
62/345,283 →
Dosing Regimens for Beta-3 Adrenoceptor Agonists and Anti-Muscarinic Agents for the Treatment and Prevention of Lower Urinary Tract Symptoms
Application:
62/345,655 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 10, 2018
From: ALTHERX, INC.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044587/0747 →
Assignment of Assignor's Interest
Jan 10, 2018
From: OHLSTEIN, ELIOT
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044588/0767 →
Assignment of Assignor's Interest
Jan 10, 2018
From: WILKINS, H. JEFFREY
To: NST CONSULTING, LLC
Reel/Frame 044588/0945 →
Assignment of Assignor's Interest
Jan 10, 2018
From: NST CONSULTING, LLC
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044589/0031 →
Assignment of Assignor's Interest
Jan 10, 2018
From: OHLSTEIN, ELIOT
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 044589/0724 →
Security Interest
Oct 7, 2019
From: VELICEPT THERAPEUTICS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 050642/0074 →